UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 852

Sortiert nach

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

The Lancet (British edition), 2008-06, Vol.371 (9630), p.2085-2092

2008

Volltextzugriff (PDF)

Volatile Compounds, Odour and Flavour Attributes of Lamb Meat from the Navarra Breed as Affected by Ageing

Foods, 2021-02, Vol.10 (3), p.493

2021

Volltextzugriff (PDF)

Physicochemical and Sensory Assessments in Spain and United States of PGI-Certified Ternera de Navarra vs. Certified Angus Beef

Foods, 2021-06, Vol.10 (7), p.1474

2021

Volltextzugriff (PDF)

Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study

Multiple sclerosis, 2010-11, Vol.16 (11), p.1360-1366

2010

Volltextzugriff (PDF)

Association of HLA-DRB115 allele and CSF oligoclonal bands in a Spanish multiple sclerosis cohort

European journal of neurology, 2011-10, Vol.18 (10), p.1258-1262

2011

Volltextzugriff (PDF)

Characteristics of multiple sclerosis at onset and delay of diagnosis and treatment in Spain (The Novo Study)

Journal of neurology, 2010-09, Vol.257 (9), p.1500-1507

2010

Volltextzugriff (PDF)

Effect of glatiramer acetate (Copaxone ®) on the immunophenotypic and cytokine profile and BDNF production in multiple sclerosis: A longitudinal study

Neuroscience letters, 2006-10, Vol.406 (3), p.270-275

2006

Volltextzugriff (PDF)

HLA-DRB1: genetic susceptibility and disability progression in a Spanish multiple sclerosis population

European journal of neurology, 2011-02, Vol.18 (2), p.337-342

2011

Volltextzugriff (PDF)

Clinical and MRI outcome after autologous hematopoietic stem cell transplantation in MS

Neurology, 2004-01, Vol.62 (2), p.282

2004

Volltextzugriff (PDF)

Anticipation of age at onset in familial multiple sclerosis

European journal of neurology, 2010-04, Vol.17 (4), p.572-575

2010

Volltextzugriff (PDF)

Consensus Statement on medication use in multiple sclerosis by the Spanish Society of Neurology's study group for demyelinating diseases

Neurologia (Barcelona, Spain), 2013-07, Vol.28 (6), p.375

2013

Volltextzugriff (PDF)

Multiple sclerosis and cognitive decline: is ApoE-4 a surrogate marker?

Acta neurologica Scandinavica, 2011-10, Vol.124 (4), p.258-263

2011

Volltextzugriff (PDF)

Spanish Neurology Society consensus document on the use of drugs in multiple sclerosis: escalating therapy

Neurologia (Barcelona, Spain), 2010-07, Vol.25 (6), p.378-390

2010

Volltextzugriff (PDF)

Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases

Multiple sclerosis, 2006-04, Vol.12 (2), p.169-173

2006

Volltextzugriff (PDF)

MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS

Neurology, 2001-04, Vol.56 (8), p.1084

2001

Volltextzugriff (PDF)

PND23 Cost of the Informal Care of Multiple Sclerosis in Spain

Value in health, 2011-11, Vol.14 (7), p.A321-A321

2011

Volltextzugriff (PDF)

PND19 Cost Of The Relapse Of Multiple Sclerosis In Spain

Value in health, 2011-11, Vol.14 (7), p.A320-A320

2011

Volltextzugriff (PDF)

14-3-3 protein in the CSF as prognostic marker in early multiple sclerosis

Neurology, 2001-08, Vol.57 (4), p.722

2001

Volltextzugriff (PDF)

Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease

Journal of neuroimmunology, 1997-04, Vol.74 (1), p.55-61

1997

Volltextzugriff (PDF)

Anticipation of age at onset in multiple sclerosis: methodologic pitfalls

Acta neurologica Scandinavica, 2010-06, Vol.121 (6), p.426-428

2010

Volltextzugriff (PDF)

An approach to estimating the intangible costs of multiple sclerosis according to disability in Catalonia, Spain

Multiple sclerosis, 2007-07, Vol.13 (6), p.800-804

2007

Volltextzugriff (PDF)

Spanish consensus on the use of natalizumab (Tysabri(®))--2011

Neurologia (Barcelona, Spain), 2012-09, Vol.27 (7), p.432

2012

Volltextzugriff (PDF)

Clinical outcome 6 years after autologous hematopoietic stem cell transplantation in multiple sclerosis

Neurología (Barcelona, Spain), 2008-09, Vol.23 (7), p.405-407

2008

Volltextzugriff (PDF)

Consensus statement on medication use in multiple sclerosis by the Spanish Society of Neurology's study group for demyelinating diseases

Neurología (Barcelona, English ed. ), 2013-07, Vol.28 (6), p.375-378

2013

Volltextzugriff (PDF)

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial

Neurology, 2016-09, Vol.87 (10), p.978

2016

Volltextzugriff (PDF)

1 – 25 von 852

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(764)
Mit Volltextzugriff
(747)

Publikationsform

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

Volatile Compounds, Odour and Flavour Attributes of Lamb Meat from the Navarra Breed as Affected by Ageing

Physicochemical and Sensory Assessments in Spain and United States of PGI-Certified Ternera de Navarra vs. Certified Angus Beef

Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study

Association of HLA-DRB115 allele and CSF oligoclonal bands in a Spanish multiple sclerosis cohort

Characteristics of multiple sclerosis at onset and delay of diagnosis and treatment in Spain (The Novo Study)

Effect of glatiramer acetate (Copaxone ®) on the immunophenotypic and cytokine profile and BDNF production in multiple sclerosis: A longitudinal study

HLA-DRB1: genetic susceptibility and disability progression in a Spanish multiple sclerosis population

Clinical and MRI outcome after autologous hematopoietic stem cell transplantation in MS

Anticipation of age at onset in familial multiple sclerosis

Consensus Statement on medication use in multiple sclerosis by the Spanish Society of Neurology's study group for demyelinating diseases

Multiple sclerosis and cognitive decline: is ApoE-4 a surrogate marker?

Spanish Neurology Society consensus document on the use of drugs in multiple sclerosis: escalating therapy

Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases

MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS

PND23 Cost of the Informal Care of Multiple Sclerosis in Spain

PND19 Cost Of The Relapse Of Multiple Sclerosis In Spain

14-3-3 protein in the CSF as prognostic marker in early multiple sclerosis

Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease

Anticipation of age at onset in multiple sclerosis: methodologic pitfalls

An approach to estimating the intangible costs of multiple sclerosis according to disability in Catalonia, Spain

Spanish consensus on the use of natalizumab (Tysabri(®))--2011

Clinical outcome 6 years after autologous hematopoietic stem cell transplantation in multiple sclerosis

Consensus statement on medication use in multiple sclerosis by the Spanish Society of Neurology's study group for demyelinating diseases

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial

Suchergebnisse filtern